Bicara Therapeutics Inc. (BCAX) Free cash flow 2023–2025
Bicara Therapeutics Inc. (BCAX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$107.1MFY2025 · since FY2023: -$46.2M → -$107.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$107.1M | -43.2% |
| FY2024 | -$74.8M | -61.9% |
| FY2023 | -$46.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More BCAX financial trends
BCAX RevenueBCAX Net incomeBCAX Net marginBCAX Gross profitBCAX Gross marginBCAX Operating incomeBCAX Operating marginBCAX Operating cash flowBCAX Capital expendituresBCAX Return on equityBCAX Stock buybacksBCAX Dividends paidBCAX Total assetsBCAX Total liabilitiesBCAX Shareholders’ equityBCAX overview →